By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma. (Q47878727)
Jump to navigation
Jump to search
scientific article published on 31 August 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma. |
scientific article published on 31 August 2017 |
Statements
By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma (English)
Qiang Yu
Weiqi Dai
Wenhui Mo
Jingjing Li
Jiao Feng
Liwei Wu
Tong Liu
Shizan Xu
Wenwen Wang
Xiya Lu
Qinghui Zhang
Kan Chen
Yujing Xia
Jie Lu
Xiaoming Fan
14 September 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference